For patients with severe calcification or complex non-calcified plaques, we investigate wether PCCT can enable non-invasive, in vivo precise differentiation and quantitative measurement of plaque components (e.g., spotty calcification, necrotic core, fibrous tissue). Further we also study wether these quantitative imaging features can independently predict the risk of MACE in the short term and long term
Adult patients (≥18 years) with clinically diagnosed coronary artery disease or undergoing CCTA for chest pain/heart failure symptoms.
Able and willing to provide informed consent and complete scheduled follow-up visits.
History of iodine contrast agent allergy.
Severe renal insufficiency (eGFR < 30 mL/min/1.73 m²).
History of prior coronary artery bypass grafting (CABG).
Pregnant or lactating women